{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:36:47Z","timestamp":1793763407636,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023T160154"],"award-info":[{"award-number":["2023T160154"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH-TZ2406"],"award-info":[{"award-number":["LBH-TZ2406"]}],"id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22205048"],"award-info":[{"award-number":["22205048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["YJSCX2024-52HYD"],"award-info":[{"award-number":["YJSCX2024-52HYD"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012548","name":"Heilongjiang Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218398","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:32:49Z","timestamp":1772497969000},"page":"218398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ETV4 lysine 2-hydroxyisobutyrylation promotes intrahepatic cholangiocarcinoma progression by suppressing ferroptosis through TXNIP downregulation"],"prefix":"10.1016","volume":"646","author":[{"given":"Jiaming","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoting","family":"E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218398_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tibs.2023.10.004","article-title":"UFMylation: a ubiquitin-like modification","volume":"49","author":"Zhou","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218398_bib2","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gkae1005","article-title":"dbPTM 2025 update: comprehensive integration of PTMs and proteomic data for advanced insights into cancer research","volume":"53","author":"Chung","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218398_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41420-025-02410-2","article-title":"Functions and mechanisms of non-histone post-translational modifications in cancer progression","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218398_bib4","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218398_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s42255-024-00992-2","article-title":"Histone butyrylation in the mouse intestine is mediated by the microbiota and associated with regulation of gene expression","volume":"6","author":"Gates","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218398_bib6","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1039\/D4SC02076F","article-title":"Enrichment of histone tail methylated lysine residues via cavitand-decorated magnetic nanoparticles for ultra-sensitive proteomics","volume":"15","author":"Orlandini","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.canlet.2026.218398_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13072-025-00577-7","article-title":"Lysine crotonylation in disease: mechanisms, biological functions and therapeutic targets","volume":"18","author":"Ji","year":"2025","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.canlet.2026.218398_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41557-024-01500-5","article-title":"Deciphering functional roles of protein succinylation and glutarylation using genetic code expansion","volume":"16","author":"Weyh","year":"2024","journal-title":"Nat. Chem."},{"key":"10.1016\/j.canlet.2026.218398_bib9","article-title":"Advances in post-translational modifications of proteins and cancer immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218398_bib10","article-title":"Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy","volume":"277","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.canlet.2026.218398_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41419-023-06406-7","article-title":"The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations","volume":"15","author":"Feng","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218398_bib12","article-title":"A novel 167-Amino acid protein encoded by CircPCSK6 inhibits intrahepatic cholangiocarcinoma progression via IKBalpha ubiquitination","volume":"12","author":"Guan","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218398_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-024-03006-x","article-title":"N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218398_bib14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1186\/s12967-023-04613-6","article-title":"Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt\/beta-catenin signal pathway","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218398_bib15","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218398_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2024.04.010","article-title":"Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD","volume":"81","author":"Yang","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218398_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.molcel.2023.11.042","article-title":"OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB","volume":"84","author":"Ma","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218398_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70070","article-title":"Lactylation in cancer: mechanisms in tumour biology and therapeutic potentials","volume":"14","author":"He","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218398_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/0008-5472.CAN-23-2664","article-title":"Post-translational modification of PD-1: potential targets for cancer immunotherapy","volume":"84","author":"Lee","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218398_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7150\/ijbs.101861","article-title":"Targeting protein modification: a new direction for immunotherapy of pancreatic cancer","volume":"21","author":"Ge","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218398_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101173","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218398_bib22","first-page":"3083","article-title":"Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer","volume":"10","author":"Qi","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218398_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhep.2023.04.005","article-title":"The role of ETV4 in HCC: how transcription factors can inform immunotherapy combination treatments","volume":"79","author":"Craig","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218398_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/cac2.12482","article-title":"Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-alpha signaling","volume":"43","author":"Qi","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218398_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2","volume":"79","author":"Xie","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218398_bib26","article-title":"ETV4 mediated tumor-associated neutrophil infiltration facilitates lymphangiogenesis and lymphatic metastasis of bladder cancer","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218398_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41388-023-02641-6","article-title":"HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218398_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40170-025-00387-1","article-title":"ETV4\/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma","volume":"13","author":"Wang","year":"2025","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.canlet.2026.218398_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nchembio.1497","article-title":"Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark","volume":"10","author":"Dai","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-025-01838-8","article-title":"Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation","volume":"17","author":"Wang","year":"2025","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2026.218398_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Liao","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2026.218398_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108142","article-title":"Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218398_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00018-024-05505-8","article-title":"MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2","volume":"81","author":"Chen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2026.218398_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.tcb.2024.01.002","article-title":"SUMO proteases: from cellular functions to disease","volume":"34","author":"Claessens","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib35","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","article-title":"SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis","volume":"12","author":"Shangguan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218398_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-024-02124-6","article-title":"Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1","volume":"23","author":"Zang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218398_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","article-title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218398_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jare.2024.04.009","article-title":"Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer","volume":"69","author":"Luo","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.canlet.2026.218398_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103267","article-title":"SENP3 sensitizes macrophages to ferroptosis via de-SUMOylation of FSP1","volume":"75","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib40","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/s44319-024-00250-2","article-title":"SUMOylation of protein phosphatase 5 regulates phosphatase activity and substrate release","volume":"25","author":"Sager","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2026.218398_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s11658-024-00624-3","article-title":"Crosstalk between SUMOylation and other post-translational modifications in breast cancer","volume":"29","author":"Wei","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218398_bib42","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gkac935","article-title":"FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218398_bib43","article-title":"The overexpression of actin related protein 2\/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression via activation of the Wnt\/beta-catenin signaling pathway","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218398_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218398_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s42003-024-06430-z","article-title":"Tumor suppressor Par-4 activates autophagy-dependent ferroptosis","volume":"7","author":"Subburayan","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216075","article-title":"IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression","volume":"557","author":"Xiao","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218398_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218398_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107660","article-title":"ComDock: a novel approach for protein-protein docking with an efficient fusing strategy","volume":"167","author":"Meng","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218398_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-024-01003-y","article-title":"Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells","volume":"31","author":"Huang","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2026.218398_bib50","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1074\/jbc.M115.713370","article-title":"Transcription factor hDREF is a novel SUMO E3 ligase of Mi2alpha","volume":"291","author":"Yamashita","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218398_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41467-023-44349-x","article-title":"Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218398_bib52","doi-asserted-by":"crossref","first-page":"W238","DOI":"10.1093\/nar\/gkae346","article-title":"GPS-SUMO 2.0: an updated online service for the prediction of SUMOylation sites and SUMO-interacting motifs","volume":"52","author":"Gou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218398_bib53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","article-title":"Signalling mechanisms and cellular functions of SUMO","volume":"23","author":"Vertegaal","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","article-title":"Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218398_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae036","article-title":"Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression","volume":"16","author":"Tian","year":"2025","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218398_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218398_bib57","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","article-title":"An artificial intelligence accelerated virtual screening platform for drug discovery","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218398_bib58","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13341","article-title":"ETV4-mediated transcriptional activation of SLC12A5 exacerbates ferroptosis resistance and glucose metabolism reprogramming in breast cancer cells","volume":"30","author":"Wang","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2026.218398_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s11658-024-00605-6","article-title":"alpha-Ketoglutarate alleviates osteoarthritis by inhibiting ferroptosis via the ETV4\/SLC7A11\/GPX4 signaling pathway","volume":"29","author":"He","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2026.218398_bib60","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/HEP.0000000000000206","article-title":"Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma","volume":"79","author":"Cantallops Vila","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218398_bib61","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2018.04.011","article-title":"p300-Mediated lysine 2-Hydroxyisobutyrylation regulates glycolysis","volume":"70","author":"Huang","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218398_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106915","article-title":"PIAS3 promotes ferroptosis by regulating TXNIP via TGF-beta signaling pathway in hepatocellular carcinoma","volume":"196","author":"Bao","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218398_bib63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2021.09.013","article-title":"Disrupting CISD2 function in cancer cells primarily impacts mitochondrial labile iron levels and triggers TXNIP expression","volume":"176","author":"Karmi","year":"2021","journal-title":"Free Radic. Biol. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:41:56Z","timestamp":1776858116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"alternative-id":["S0304383526001618"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218398","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ETV4 lysine 2-hydroxyisobutyrylation promotes intrahepatic cholangiocarcinoma progression by suppressing ferroptosis through TXNIP downregulation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218398"}}